Naltrexone is a long acting opioid antagonist that is used in rehabilitation programmes to maintain heroin abstinence. It is a relatively new drug prescribed by specialists in substance misuse. Its actions and eVects may not be familiar to many accident and emergency doctors or even to the people who take it. A case report is described where accidental ingestion of naltrexone results in a medical emergency by precipitating acute withdrawal in a heroin addict. (Emerg Med J 2001;18:494-495) Keywords: naltrexone; opioids
Discussion
The oral dose of naltrexone is 25 mg increasing to 50 mg per day and it has a prolonged eVect of 24 to 72 hours. Patients have to be opioid free for 7-10 days and are given a supervised naloxone challenge before administration. Side eVects include nausea, vomiting, anxiety, nervousness, headache, sleep disturbance, diarrhoea, sweating and excess lacrimation, and joint and muscle pain.
1 The use of naltrexone improves short-term outcomes in opioid detoxification programmes and it may have a place in the treatment of general substance misuse including alcoholism where it not only exerts a physical eVect in preventing alcohol reuse but also reduces the psychological craving.
2 Ultra rapid detoxification uses naltrexone administered to addicts under deep sedation or general anaesthesia.
When a patient currently taking naltrexone requires opioid analgesia a rapidly acting opioid should be carefully titrated under close monitoring and with resuscitation equipment available. Large amounts of opioid may be required and non-receptor eVects can occur (facial swelling, itching and erythema). In this situation there is also an increased risk of cardiorespiratory collapse (personal correspondence from DuPont Pharma). Unexpected overdose is recognised in previous naltrexone patients who return to substance misuse and discover a heightened sensitivity to opioid eVects.
Treatment of accidental ingestion of naltrexone in opioid dependants is supportive with intravenous fluids, antiemetics, non-opioid analgesia, benzodiazepines and the treatment of any cardiorespiratory compromise (personal correspondence from DuPont Pharma) and Manelli et al. 3 Symptoms like confusion, somnolence and visual hallucinations appear within five minutes and last up to 48 hours (personal correspondence from DuPont Pharma). There may be significant fluid losses from vomiting and diarrhoea. There is increased sympathetic activity and catecholamine release and the resultant tachycardia can be used to monitor the reversal of opioid dependence. 4 Opioid administration, including methadone, is fruitless and potentially dangerous. The precise pharmacodynamics are not completely understood and large diVerences in serum concentrations of the drug have been demonstrated and are thought to reflect variable first pass metabolism. 5 The nature, severity and duration of accidental withdrawal varies greatly between people and the clinical course is not predictable. maintained on naltrexone in the community, there is increasing potential for this drug to be taken by current opioid dependent people and we may see more cases of unintentional "rapid detoxification" presenting to our accident and emergency departments. 
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